Companies signing the position paper included 3M, Abbott, Apotex, Axway, Baxter, Bayer, BD, B.Braun, Boehringer Ingelheim, Canadian Generic Pharmaceutical Association, Cardinal Health, CH2, Covidien, Fedefarma, Fresenius Kabi, Johnson & Johnson, McKesson, Mölnlycke, Novation, Pfizer, Premier, RX360 and Sanofi Pasteur.